相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
Carolina Caro-Vegas et al.
MBIO (2019)
A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
Hye Joung Choi et al.
GYNECOLOGIC ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Exploring Biomarkers of Phosphoinositide 3-Kinase Pathway Activation in the Treatment of Hormone Receptor Positive, Human Epidermal Growth Receptor 2 Negative Advanced Breast Cancer
Virginia G. Kaklamani et al.
ONCOLOGIST (2019)
Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment
Alina Sesarman et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Impact of p85α Alterations in Cancer
Jeremy D. S. Marshall et al.
BIOMOLECULES (2019)
The Role of mTOR in Ovarian Cancer, Polycystic Ovary Syndrome, and Ovarian Aging
Jin Liu et al.
CLINICAL ANATOMY (2018)
INPP4B restrains cell proliferation and metastasis via regulation of the PI3K/AKT/SGK pathway
Ying Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer
Mei Ding et al.
MOLECULAR CANCER RESEARCH (2018)
Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells
Alina Sesarman et al.
PHARMACOLOGICAL REPORTS (2018)
Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance
Augustin Le Naour et al.
Oncotarget (2018)
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Brandon Bumbaca et al.
ACTA PHARMACEUTICA SINICA B (2018)
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
Fabiana Conciatori et al.
CANCERS (2018)
PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer
Diyou Li et al.
ANALYTICAL CELLULAR PATHOLOGY (2018)
Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to date
Felix A. Mensah et al.
ONCOTARGETS AND THERAPY (2018)
Cordycepin induces apoptosis of human ovarian cancer cells by inhibiting CCL5-mediated Akt/NF-κB signaling pathway
Zhen Yang Cui et al.
CELL DEATH DISCOVERY (2018)
MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway
Zeinab Amini-Farsani et al.
CYTOTECHNOLOGY (2018)
Tumor evolution and chemoresistance in ovarian cancer
Soochi Kim et al.
NPJ PRECISION ONCOLOGY (2018)
Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
Kaiming Sun et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Chemoresistance and targeted therapies in ovarian and endometrial cancers
Kevin Brasseur et al.
ONCOTARGET (2017)
PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Maria Luisa Gasparri et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2017)
PtdIns3P controls mTORC1 signaling through lysosomal positioning
Zhi Hong et al.
JOURNAL OF CELL BIOLOGY (2017)
Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-κB-TNFα-PIK3CA loop
Bhushan Thakur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Cepharanthine hydrochloride reverses P-glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway
Chen-Zheng Huang et al.
ONCOLOGY REPORTS (2017)
A Review of mTOR Pathway Inhibitors in Gynecologic Cancer
Andreia Cristina de Melo et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Preclinical study of CC223 as a potential anti-ovarian cancer agent
Zhenzhen Jin et al.
ONCOTARGET (2017)
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells
Carrie D. House et al.
CANCER RESEARCH (2017)
NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells
Carolina Gonzalez-Torres et al.
ARCHIVES OF MEDICAL RESEARCH (2017)
The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer
Jennifer M. Spangle et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor
Johanna C. Bendell et al.
BRITISH JOURNAL OF CANCER (2017)
Unraveling the regulation of mTORC2 using logical modeling
Kirsten Thobe et al.
CELL COMMUNICATION AND SIGNALING (2017)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
c-Rel and its many roles in cancer: an old story with new twists
Jill E. Hunter et al.
BRITISH JOURNAL OF CANCER (2016)
AKT in cancer: new molecular insights and advances in drug development
Prabhjot S. Mundi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling
Shu Tang et al.
CANCER LETTERS (2016)
Targeting Inflammation in Cancer Prevention and Therapy
Jelena Todoric et al.
CANCER PREVENTION RESEARCH (2016)
4E-BP1, a multifactor regulated multifunctional protein
Xiaoyu Qin et al.
CELL CYCLE (2016)
The rise of genomic profiling in ovarian cancer
Rebecca A. Previs et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy
Christos E. Zois et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
A. R. Ozes et al.
ONCOGENE (2016)
Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis
J. Musa et al.
ONCOGENE (2016)
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer
Dong Wang et al.
ONCOTARGET (2016)
Akt isoform specific effects in ovarian cancer progression
Nicolle M. Linnerth-Petrik et al.
ONCOTARGET (2016)
BKM-120 (Buparlisib): A Phosphatidyl-Inositol-3 Kinase Inhibitor with Anti-Invasive Properties in Glioblastoma
Maria-Carmela Speranza et al.
SCIENTIFIC REPORTS (2016)
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
Seiji Mabuchi et al.
GYNECOLOGIC ONCOLOGY (2015)
The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer
Zhi Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Phosphoinositide-specific phospholipase C in health and disease
Lucio Cocco et al.
JOURNAL OF LIPID RESEARCH (2015)
PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
Pengda Liu et al.
CANCER DISCOVERY (2015)
Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment
Laura R. H. Ip et al.
ONCOTARGET (2015)
The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines
Huimin Bai et al.
ONCOTARGET (2015)
A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation
Guang Yang et al.
CELL REPORTS (2015)
The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
Bianca Cheaib et al.
CHINESE JOURNAL OF CANCER (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression
Huijuan Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway
Nasser Ghaly Yousif
CELL BIOLOGY INTERNATIONAL (2014)
Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by IκB Kinase α (IKKα)
Han C. Dan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Classes of phosphoinositide 3-kinases at a glance
Steve Jean et al.
JOURNAL OF CELL SCIENCE (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
NF-κB is a critical mediator of BRCA1-induced chemoresistance
M. T. Harte et al.
ONCOGENE (2014)
The Role of the PTEN/PI3K/Akt Pathway on Prognosis in Epithelial Ovarian Cancer: AMeta-Analysis
Jing Cai et al.
ONCOLOGIST (2014)
NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
Masaya Uno et al.
PLOS ONE (2014)
PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context
Fabienne Schmit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The structural basis for mTOR function
Domagoj Baretic et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Role of integrin alpha4 in drug resistance of leukemia
Stephanie Shishido et al.
FRONTIERS IN ONCOLOGY (2014)
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
Filipe C. Martins et al.
GENOME BIOLOGY (2014)
Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy
Hai-Xin Yuan et al.
AUTOPHAGY (2013)
The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
Hui Cai et al.
CELL COMMUNICATION AND SIGNALING (2013)
PI3K Pathway Dependencies in Endometrioid Endometrial Cancer Cell Lines
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2013)
Immune escape of AKT overexpressing ovarian cancer cells
Jens C. Hahne et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Curcumin Suppresses Doxorubicin-Induced Epithelial-Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells
Wei-Chih Chen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate
York Posor et al.
NATURE (2013)
mTOR kinase structure, mechanism and regulation
Haijuan Yang et al.
NATURE (2013)
The evolution of the TOR pathway and its role in cancer
E. M. Beauchamp et al.
ONCOGENE (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Identification of ovarian cancer driver genes by using module network integration of multi-omics data
Olivier Gevaert et al.
INTERFACE FOCUS (2013)
Targeting nuclear factor-kappa B to overcome resistance to chemotherapy
P. Godwin et al.
FRONTIERS IN ONCOLOGY (2013)
Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
Inma M. Berenjeno et al.
BIOCHEMICAL JOURNAL (2012)
Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review
J. Borley et al.
BRITISH JOURNAL OF CANCER (2012)
Renin activates PI3K-Akt-eNOS signalling through the angiotensin AT1 and Mas receptors to modulate central blood pressure control in the nucleus tractus solitarii
Wen-Han Cheng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
Balazs Gyoerffy et al.
ENDOCRINE-RELATED CANCER (2012)
Perifosine, an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity
Paul G. Richardson et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways
Min Huan Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice
Kathryn M. Kinross et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer
Craig P. Carden et al.
MOLECULAR CANCER THERAPEUTICS (2012)
PI3K signalling: the path to discovery and understanding
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro
J. C. Hahne et al.
ONCOLOGY REPORTS (2012)
Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
Aphrothiti J. Hanrahan et al.
CANCER DISCOVERY (2012)
Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110β as a Potential Anticancer Agent
Jing Ni et al.
CANCER DISCOVERY (2012)
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis
Xiaofeng Zhao et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
Guri Tzivion et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFκB pathway
Ilana Chefetz et al.
CELL CYCLE (2011)
Structural studies of NF-kappa B signaling
Chao Zheng et al.
CELL RESEARCH (2011)
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors
Francesco Dituri et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Frequent Genetic Abnormalities of the PI3K/AKT Pathway in Primary Ovarian Cancer Predict Patient Outcome
Jia Huang et al.
GENES CHROMOSOMES & CANCER (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
Dong-Jun Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Acetylation of p65 at lysine 314 is important for late NF-κB-dependent gene expression
Karin M. Rothgiesser et al.
BMC GENOMICS (2010)
Nuclear Factor κB Transcription Factors Are Coexpressed and Convey a Poor Outcome in Ovarian Cancer
Christina M. Annunziata et al.
CANCER (2010)
Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival
Bryan C. Barnhart et al.
CANCER BIOLOGY & THERAPY (2010)
Activation of NF-KB Signaling by Inhibitor of NF-KB Kinase β Increases Aggressiveness of Ovarian Cancer
Lidia Hernandez et al.
CANCER RESEARCH (2010)
Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
Calvin K. Yip et al.
MOLECULAR CELL (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
Natini Jinawath et al.
PLOS ONE (2010)
Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
Clare G. Fedele et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer
Jeffrey J. Wallin et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Dominico Vigil et al.
NATURE REVIEWS CANCER (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
Christina Gewinner et al.
CANCER CELL (2009)
The Akt kinases Isoform specificity in metabolism and cancer
Eva Gonzalez et al.
CELL CYCLE (2009)
Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
Lilach Kleinberg et al.
HUMAN PATHOLOGY (2009)
Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
Abdalla J. Mohamed et al.
IMMUNOLOGICAL REVIEWS (2009)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction?
Mathew Vadas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway
Byeong Hyeok Choi et al.
CANCER LETTERS (2008)
Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms
HuiJuan Wu et al.
CANCER LETTERS (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Targeting SphK1 as a new strategy against cancer
Dai Shida et al.
CURRENT DRUG TARGETS (2008)
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Han C. Dan et al.
GENES & DEVELOPMENT (2008)
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2
Jingxiang Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis
Shidong Jia et al.
NATURE (2008)
A putative mitotic checkpoint dependent on mTOR function controls cell proliferation and survival in ovarian granulosa cells
Aylin Yaba et al.
REPRODUCTIVE SCIENCES (2008)
The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner
Hellinida Thomadaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer
Steve Braunstein et al.
MOLECULAR CELL (2007)
Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2β-AKT pathway
Margaret Das et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
Dung-Fang Lee et al.
CELL (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Regulation of mammalian target of rapamycin activity in PTEN-inactive prostate cancer cells bv IκB kinase α
Han C. Dan et al.
CANCER RESEARCH (2007)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
GEFs and GAPs: Critical elements in the control of small G proteins
Johannes L. Bos et al.
CELL (2007)
EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway
Robert J. George et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer
Josep Castellvi et al.
CANCER (2006)
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
Kentaro Nakayama et al.
CANCER BIOLOGY & THERAPY (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Mip1, an MEKK2-interacting protein, controls MEKK2 dimerization and activation
J Cheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Role for Akt3/Protein kinase Bγ in attainment of normal brain size
RM Easton et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappa B pathway by lysophosphatidic acid, an ovarian cancer-activating factor
CH Chou et al.
CARCINOGENESIS (2005)
Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion
JN Hutchinson et al.
CANCER RESEARCH (2004)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of αvβ3 and α5β1 integrins
MS Roberts et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
DA Altomare et al.
ONCOGENE (2004)
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
J Luo et al.
CANCER CELL (2003)
Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation
LF Chen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome
JW Cheong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
BRCA1 augments transcription by the NF-κB transcription factor by binding to the rel domain of the p65/RelA subunit
M Benezra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer
N Terakawa et al.
ENDOCRINE-RELATED CANCER (2003)
Disparate expression of the PTEN gene:: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL)
N Leupin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma
M Tachibana et al.
CANCER (2002)
Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
H Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38
LV Madrid et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)
H Cho et al.
SCIENCE (2001)
Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway
D Koul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The IκB kinase (IKK) and NF-κB:: key elements of proinflammatory signalling
M Karin et al.
SEMINARS IN IMMUNOLOGY (2000)
分享论文
